Microfibrillar-associated protein 4 as a potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: Pathological and clinical aspects
Multiple Sclerosis Journal · 2023
DOI: 10.1177/13524585231200720 ↗Kurz gefasst
Fachartikel in der Zeitschrift Multiple Sclerosis Journal, 2023. Verfasst von Sara Samadzadeh und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Regional Health Research, University of Southern Denmark, Odense, Denmark. Hauptthemen laut MEDLINE: Multiple Sclerosis, Neuromyelitis Optica, Multiple Sclerosis, Chronic Progressive. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, NINDS NIH HHS, The Slagelse Hospital Research Fund.
Abstract (Originalsprache)
Background
Microfibrillar-associated protein 4 (MFAP4) is an extracellular matrix protein not previously described in the human central nervous system (CNS).
Objectives
We determined MFAP4 CNS expression and measured cerebrospinal fluid (CSF) and serum levels.
Methods
Tissue was sampled at autopsy from patients with acute multiple sclerosis (MS) ( n = 3), progressive MS ( n = 3), neuromyelitis optica spectrum disorder (NMOSD) ( n = 2), and controls ( n = 9), including 6 healthy controls (HC). MFAP4 levels were measured in 152 patients: 49 MS, 62 NMOSD, 22 myelin oligodendrocyte glycoprotein-associated disease (MOGAD), and 19 isolated optic neuritis (ION).
Results
MFAP4 localized to meninges and vascular/perivascular spaces, intense in the optic nerve. At sites of active inflammation, MFAP4 reactivity was reduced in NMOSD and acute MS and less in progressive MS. CSF MFAP4 levels were reduced during relapse and at the onset of diseases (mean U/mL: MS 14.3, MOGAD 9.7, and ION 14.6 relative to HC 17.9. ( p = 0.013, p = 0.000, and p = 0.019, respectively). Patients with acute ON ( n = 68) had reduced CSF MFAP4 (mean U/mL: 14.5, p = 0.006). CSF MFAP4 levels correlated negatively with relapse severity (rho = −0.41, p = 0.017).
Conclusion
MFAP4 immunoreactivity was reduced at sites of active inflammation. CSF levels of MFAP4 were reduced following relapse and may reflect disease activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
- Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
- Department of Neurology, Slagelse Hospital, Slagelse, Denmark/Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Berlin, Germany.
- Department of Neurology, Slagelse Hospital, Slagelse, Denmark/Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
- Department of Pathological Anatomy and Molecular Biology, Hospital South West Jutland, Esbjerg, Denmark.
- Open Patient Data Explorative Network, Odense University Hospital, University of Southern Denmark, Odense, Denmark.
ORCID-Profile: Romain Marignier, Eoin P Flanagan, Sean J Pittock, Ho Jin Kim
Förderung
- NEI NIH HHS
- NINDS NIH HHS
- The Slagelse Hospital Research Fund
- The Danish Multiple Sclerosis Society
- The University of Southern Denmark Fund
Zitieren
APA
Samadzadeh, S., Olesen, M. N., Wirenfeldt, M., Möller, S., Misu, T., Soelberg, K., Frederiksen, J. L., Heegaard, S., Mariotto, S., Fujihara, K., Ruprecht, K., Andersen, T. L., Marignier, R., Lillevang, S. T., Flanagan, E. P., Pittock, S. J., Kim, H. J., Bennett, J. L., Paul, F., …, & Asgari, N. (2023). Microfibrillar-associated protein 4 as a potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: Pathological and clinical aspects. Multiple Sclerosis Journal. https://doi.org/10.1177/13524585231200720
Vancouver
Samadzadeh S, Olesen MN, Wirenfeldt M, Möller S, Misu T, Soelberg K, et al. Microfibrillar-associated protein 4 as a potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: Pathological and clinical aspects. Multiple Sclerosis Journal. 2023. doi:10.1177/13524585231200720
BibTeX
@article{Samadzadeh2023,
author = {Samadzadeh, Sara and Olesen, Mads Nikolaj and Wirenfeldt, Martin and Möller, Sören and Misu, Tatsuro and Soelberg, Kerstin and Frederiksen, Jette Lautrup and Heegaard, Steffen and Mariotto, Sara and Fujihara, Kazuo and Ruprecht, Klemens and Andersen, Thomas Levin and Marignier, Romain and Lillevang, Søren Thue and Flanagan, Eoin P and Pittock, Sean J and Kim, Ho Jin and Bennett, Jeffrey L and Paul, Friedemann and Sorensen, Grith Lykke and Weinshenker, Brian G and Lassmann, Hans and Asgari, Nasrin},
title = {Microfibrillar-associated protein 4 as a potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: Pathological and clinical aspects},
journal = {Multiple Sclerosis Journal},
year = {2023},
doi = {10.1177/13524585231200720}
}
EUVIMED